HYPERPROTHROMBINAEMIA

This adverse event was reported 3 times

HYPERPROTHROMBINAEMIA is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 TETRAKIS(2-METHOXYISOBUTYLISOCYANIDE)COPPER(I) TETRAFLUOROBORATE 1 0.0021
1 REGORAFENIB 1 0.0001
2 LEDIPASVIR AND SOFOSBUVIR 1 0.0001
3 ASCORBIC ACID 1 0.0000
4 VITAMIN E 1 0.0000
5 CELECOXIB 1 0.0000
6 ZOLPIDEM TARTRATE 1 0.0000
7 ATORVASTATIN CALCIUM 1 0.0000
8 METOPROLOL TARTRATE 1 0.0000
9 OMEPRAZOLE MAGNESIUM 1 0.0000
See all drugs enriched for association with HYPERPROTHROMBINAEMIA

HYPERPROTHROMBINAEMIA is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Hepatitis C Virus NS5A Inhibitor [EPC] 1 0.0000
1 Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor [EPC] 1 0.0000
2 Vitamin C [EPC] 1 0.0000
3 Nonsteroidal Anti-inflammatory Drug [EPC] 1 0.0000
See all drug classes enriched for association with HYPERPROTHROMBINAEMIA